Is it unethical to treat Mgen without testing for resistance first?
Prevalence of mutations associated with resistance to macrolides
A recent meta-analysis by Dr Machalek et al, from Royal Women’s Hospital Centre for Women’s Infectious Diseases, highlights the alarming rise in global macrolide resistance and the strategies they recommend, including RGT, to combat the rise.
Read the Lancet publication
Open Letter: Emerging macrolide resistance in Mycoplasma genitalium
Cools and Padalko, Department of Diagnostic Sciences, Ghent, Belgium, lay the foundations for an interesting debate on the state of STI testing and treatment. With the alarming global rise in macrolide resistance, highlighted in the Machalek et al meta-analysis, Cools and Padalko believe ‘it is unethical not to offer systematic resistance testing before treatment of M. genitalium infection”
Read the Lancet open letter